Literature DB >> 5288385

An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.

R L Marcus, H S Shin, M M Mayer.   

Abstract

The reaction between endotoxic lipopolysaccharide (LPS) and the guinea pig complement system was shown to proceed by way of an intermediate complex, LPS-X, which contains at least six guinea pig serum proteins. LPS-X, like [unk] (sheep erythrocytes carrying antibody molecules and [unk] complexes), destroys the C3 molecule by cleavage. On incubation at 37 degrees C, LPS-X loses its capacity to destroy C3 at about the same rate as the decay of [unk], so that it has been assumed that LPS-X carries [unk] sites that are responsible for the destruction of C3. We have now shown that monospecific rabbit antiguinea pig C2, which effectively inhibits C3 cleavage by [unk], does not interfere with the destruction of C3 by LPS-X. Furthermore, not more than a trace of C2a(d) is released from LPS-X on incubation at 37 degrees C. These results indicate that LPS-X does not carry a significant quantity of [unk] and, hence, that its capacity to destroy C3 is due to another factor which is presumably a component of the properdin system.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5288385      PMCID: PMC389187          DOI: 10.1073/pnas.68.6.1351

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

2.  The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.

Authors:  A L Sandberg; A G Osler; H S Shin; B Oliveira
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

3.  The third component of the guinea pig complement system. I. Purification and characterization.

Authors:  H S Shin; M M Mayer
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

4.  The third component of the guinea pig complement system. II. Kinetic study of the reaction of EAC'4,2a with guinea pig C'3. Enzymatic nature of C'3 comsumption, multiphasic character of fixation, and hemolytic titration of C'3.

Authors:  H S Shin; M M Mayer
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

5.  A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory.

Authors:  M M Mayer; J A Miller; H S Shin
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

6.  Two complement interaction sites in guinea pig immunoglobulins.

Authors:  A L Sandberg; B Oliveira; A G Osler
Journal:  J Immunol       Date:  1971-01       Impact factor: 5.422

7.  C'2ad, an inactive derivative of C'2 released during decay of EAC'4,2a.

Authors:  R M Stroud; M M Mayer; J A Miller; A T McKenzie
Journal:  Immunochemistry       Date:  1966-05

8.  A plasmin-split fragment of C'3 as a new chemotactic factor.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

9.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  31 in total

1.  The effect of anticomplementary substances on properdin in normal and C2-deficient sera.

Authors:  R H McLean; K Townsend; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

2.  [Relations between complement and blood coagulation (author's transl)].

Authors:  G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1977-07-15

3.  Humoral bactericidal systems: nonspecific and specific mechanisms.

Authors:  R C Skarnes
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

4.  Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

Authors:  J Hamuro; U Hadding; D Bitter-Suermann
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

5.  Activation of the alternative complement pathway by L-phase variants of gram-positive bacteria.

Authors:  F T Saulsbury; J A Winkelstein
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

6.  Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.

Authors:  H Ohta; Y Yoshikawa; C Kai; K Yamanouchi; H Okada
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

7.  Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.

Authors:  R M Des Prez; C S Bryan; J Hawiger; D G Colley
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

8.  Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.

Authors:  M A Kane; J E May; M M Frank
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota.

Authors:  F Clas; M Loos
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

Authors:  G F Webster; U R Nilsson; W P McArthur
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.